穿心莲和苧麻提取物对金色叙利亚仓鼠 SARS-CoV-2 Delta 变异株的体内活性评估:COVID-19治疗的潜在草药替代品

IF 3.3 3区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
{"title":"穿心莲和苧麻提取物对金色叙利亚仓鼠 SARS-CoV-2 Delta 变异株的体内活性评估:COVID-19治疗的潜在草药替代品","authors":"","doi":"10.1016/j.jtcme.2024.05.004","DOIUrl":null,"url":null,"abstract":"<div><div>The ongoing COVID-19 pandemic has triggered extensive research, mainly focused on identifying effective therapeutic agents, specifically those targeting highly pathogenic SARS-CoV-2 variants. This study aimed to investigate the <em>in vivo</em> antiviral efficacy and anti-inflammatory activity of herbal extracts derived from <em>Andrographis paniculata</em> and <em>Boesenbergia rotunda</em>, using a Golden Syrian hamster model infected with Delta, a representative variant associated with severe COVID-19. Hamsters were intranasally inoculated with the SARS-CoV-2 Delta variant and orally administered either vehicle control, <em>B. rotunda</em>, or <em>A.</em> <em>paniculata</em> extract at a dosage of 1000 mg/kg/day. Euthanasia was conducted on days 1, 3, and 7 post-inoculation, with 4 animals per group. The results demonstrated that oral administration of <em>A. paniculata</em> extract significantly alleviated both lethality and infection severity compared with the vehicle control and <em>B. rotunda</em> extract. However, neither extract exhibited direct antiviral activity in terms of reducing viral load in the lungs. Nonetheless, <em>A. paniculata</em> extract treatment significantly reduced IL-6 protein levels in the lung tissue (7278 ± 868.4 pg/g tissue) compared to the control (12,495 ± 1118 pg/g tissue), indicating there was a decrease in local inflammation. This finding is evidenced by the ability of <em>A. paniculata</em> extract to reduce histological lesions in the lungs of infected hamsters. Furthermore, both extracts significantly decreased IL-6 and IP-10 mRNA expression in peripheral blood mononuclear cells of infected hamsters compared to the control group, suggesting systemic anti-inflammatory effects occurred. In conclusion, <em>A. paniculata</em> extract's potential therapeutic application for SARS-CoV-2 arises from its observed capacity to lessen inflammatory cytokine concentrations and mitigate lung pathology.</div></div>","PeriodicalId":17449,"journal":{"name":"Journal of Traditional and Complementary Medicine","volume":"14 6","pages":"Pages 598-610"},"PeriodicalIF":3.3000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In vivo evaluation of Andrographis paniculata and Boesenbergia rotunda extract activity against SARS-CoV-2 Delta variant in Golden Syrian hamsters: Potential herbal alternative for COVID-19 treatment\",\"authors\":\"\",\"doi\":\"10.1016/j.jtcme.2024.05.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The ongoing COVID-19 pandemic has triggered extensive research, mainly focused on identifying effective therapeutic agents, specifically those targeting highly pathogenic SARS-CoV-2 variants. This study aimed to investigate the <em>in vivo</em> antiviral efficacy and anti-inflammatory activity of herbal extracts derived from <em>Andrographis paniculata</em> and <em>Boesenbergia rotunda</em>, using a Golden Syrian hamster model infected with Delta, a representative variant associated with severe COVID-19. Hamsters were intranasally inoculated with the SARS-CoV-2 Delta variant and orally administered either vehicle control, <em>B. rotunda</em>, or <em>A.</em> <em>paniculata</em> extract at a dosage of 1000 mg/kg/day. Euthanasia was conducted on days 1, 3, and 7 post-inoculation, with 4 animals per group. The results demonstrated that oral administration of <em>A. paniculata</em> extract significantly alleviated both lethality and infection severity compared with the vehicle control and <em>B. rotunda</em> extract. However, neither extract exhibited direct antiviral activity in terms of reducing viral load in the lungs. Nonetheless, <em>A. paniculata</em> extract treatment significantly reduced IL-6 protein levels in the lung tissue (7278 ± 868.4 pg/g tissue) compared to the control (12,495 ± 1118 pg/g tissue), indicating there was a decrease in local inflammation. This finding is evidenced by the ability of <em>A. paniculata</em> extract to reduce histological lesions in the lungs of infected hamsters. Furthermore, both extracts significantly decreased IL-6 and IP-10 mRNA expression in peripheral blood mononuclear cells of infected hamsters compared to the control group, suggesting systemic anti-inflammatory effects occurred. In conclusion, <em>A. paniculata</em> extract's potential therapeutic application for SARS-CoV-2 arises from its observed capacity to lessen inflammatory cytokine concentrations and mitigate lung pathology.</div></div>\",\"PeriodicalId\":17449,\"journal\":{\"name\":\"Journal of Traditional and Complementary Medicine\",\"volume\":\"14 6\",\"pages\":\"Pages 598-610\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-05-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Traditional and Complementary Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2225411024000609\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Traditional and Complementary Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2225411024000609","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

正在进行的 COVID-19 大流行引发了广泛的研究,主要集中在确定有效的治疗药物,特别是那些针对高致病性 SARS-CoV-2 变体的药物。本研究旨在利用金色叙利亚仓鼠感染 Delta(一种与严重 COVID-19 相关的代表性变异体)模型,研究穿心莲和苧麻提取物的体内抗病毒功效和抗炎活性。给仓鼠鼻内接种 SARS-CoV-2 Delta 变异株,然后口服车辆对照、穿心莲或穿心莲提取物,剂量为 1000 毫克/千克/天。在接种后的第 1、3 和 7 天对每组 4 只动物实施安乐死。结果表明,与载体对照和罗汉果提取物相比,口服罗汉果提取物可显著降低致死率和感染严重程度。然而,这两种提取物都没有表现出直接的抗病毒活性,即减少肺部的病毒载量。然而,与对照组(12495 ± 1118 pg/g组织)相比,A. paniculata提取物处理可显著降低肺组织中IL-6蛋白水平(7278 ± 868.4 pg/g组织),表明局部炎症有所减轻。这一发现可以从A. paniculata提取物减少受感染仓鼠肺部组织学病变的能力中得到证明。此外,与对照组相比,两种提取物都能明显降低感染仓鼠外周血单核细胞中 IL-6 和 IP-10 mRNA 的表达,这表明提取物具有全身抗炎作用。总之,A. paniculata 提取物对 SARS-CoV-2 的潜在治疗作用源于其降低炎症细胞因子浓度和减轻肺部病理变化的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

In vivo evaluation of Andrographis paniculata and Boesenbergia rotunda extract activity against SARS-CoV-2 Delta variant in Golden Syrian hamsters: Potential herbal alternative for COVID-19 treatment

In vivo evaluation of Andrographis paniculata and Boesenbergia rotunda extract activity against SARS-CoV-2 Delta variant in Golden Syrian hamsters: Potential herbal alternative for COVID-19 treatment
The ongoing COVID-19 pandemic has triggered extensive research, mainly focused on identifying effective therapeutic agents, specifically those targeting highly pathogenic SARS-CoV-2 variants. This study aimed to investigate the in vivo antiviral efficacy and anti-inflammatory activity of herbal extracts derived from Andrographis paniculata and Boesenbergia rotunda, using a Golden Syrian hamster model infected with Delta, a representative variant associated with severe COVID-19. Hamsters were intranasally inoculated with the SARS-CoV-2 Delta variant and orally administered either vehicle control, B. rotunda, or A. paniculata extract at a dosage of 1000 mg/kg/day. Euthanasia was conducted on days 1, 3, and 7 post-inoculation, with 4 animals per group. The results demonstrated that oral administration of A. paniculata extract significantly alleviated both lethality and infection severity compared with the vehicle control and B. rotunda extract. However, neither extract exhibited direct antiviral activity in terms of reducing viral load in the lungs. Nonetheless, A. paniculata extract treatment significantly reduced IL-6 protein levels in the lung tissue (7278 ± 868.4 pg/g tissue) compared to the control (12,495 ± 1118 pg/g tissue), indicating there was a decrease in local inflammation. This finding is evidenced by the ability of A. paniculata extract to reduce histological lesions in the lungs of infected hamsters. Furthermore, both extracts significantly decreased IL-6 and IP-10 mRNA expression in peripheral blood mononuclear cells of infected hamsters compared to the control group, suggesting systemic anti-inflammatory effects occurred. In conclusion, A. paniculata extract's potential therapeutic application for SARS-CoV-2 arises from its observed capacity to lessen inflammatory cytokine concentrations and mitigate lung pathology.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Traditional and Complementary Medicine
Journal of Traditional and Complementary Medicine Medicine-Complementary and Alternative Medicine
CiteScore
9.30
自引率
6.70%
发文量
78
审稿时长
66 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信